Abbott Laboratories (NYSE: ABT) has launched its over-the-counter continuous glucose monitoring system in the U.S., the company said on Thursday, […]
Abbott (NYSE: ABT) Debuts OTC Glucose Monitoring System in the US, Rivals Dexcom Read More »
In December, Drew, a 36-year-old man from San Antonio, Texas, drove over 250 miles (400 km) to Mexico to buy
Fake Ozempic: How Batch Numbers Help Criminal Groups Spread Dangerous Drugs Read More »
The U.S. government’s first-ever negotiated prices for prescription drugs are still on average more than double, and in some cases
US Prescription Drug Prices Remain Twice as High Despite Negotiations, Reuters Finds Read More »
Novo Nordisk (NYSE: NVO) said the shortage of lower strengths of its diabetes drug Ozempic has deteriorated, with intermittent shortages
Ozempic Shortage to Persist into Q4 2024, Novo Nordisk Warns Read More »
Sanofi’s (NASDAQ: SNY) most advanced multiple sclerosis drug candidate has missed the main goal of two late-stage trials to treat
Sanofi’s (NASDAQ: SNY) Mixed Fortunes in MS Drug Trials Has Market Focus on Win Read More »
On Friday, the U.S. Food and Drug Administration granted emergency use authorization for an updated version of Novavax’s (NASDAQ: NVAX)
FDA Authorizes Novavax (NASDAQ: NVAX) Updated COVID Vaccine Targeting JN.1 Strain Read More »
The U.S. Food and Drug Administration granted expanded approval to Emergent BioSolutions’ (NYSE: EBS) smallpox vaccine for use in people
The U.S. Food and Drug Administration has mandated more people show photo identification when buying tobacco products, as the health
US FDA Changes Tobacco Sales Regulations: Photo ID Required for Under-30s Read More »
WASHINGTON – More than 1 million people in the U.S. will save over $1,000 a year beginning in 2025 when
Biden Cap on Drug Costs To Save Over 1 Million US Seniors $1,000+ Annually, Study Finds Read More »
Copyright © 2024 abbonews.com
